NSC |
Compound |
Enrichment |
Correlation |
NSC 722995 |
Null |
0.00404192617431249 |
0.33672062 |
NSC 724779 |
1-{[(1R,4S,5R,8S,12R,13R)-1,5-dimethyl-10-(trifluoromethyl)- 11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec-9- en-9-yl]methyl}-4-{[1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(tr ifluoromethyl)-1 |
0.00404192617431249 |
0.21684471 |
NSC 762911 |
6-(4-ethylphenyl)-2-(4-(methylsulfonyl)phenyl)-4,5-dihydropyridazin-3(2H)-one |
0.00404192617431249 |
0.58777013 |
NSC 763857 |
Null |
0.00404192617431249 |
0.32845146 |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
0.00501121117465287 |
0.42993716 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.00501121117465287 |
0.32131862 |
NSC 290193 |
CYCLOSPORIN A |
0.00501121117465287 |
0.37340682 |
NSC 291049 |
Null |
0.00501121117465287 |
0.027998015 |
NSC 324368 |
3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide |
0.00501121117465287 |
0.26598648 |
NSC 348121 |
4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- |
0.00501121117465287 |
0.28769614 |